Conference abstractPublished 26 Feb 2018
In silico assessment of cardiovascular adverse effects of drug-drug interactions
Institute of Biomedical Chemistry, Russia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of Problem: Adverse Drug Effects (ADEs) are one of the leading causes of death in developed countries and the main reason for drug recalls from the market. The ADEs associated with action on the cardiovascular system are the most dangerous and widespread. Treatment of human diseases often requires the intake of several drugs, which can lead to drugdrug interactions (DDIs) causing an increase in the frequency and severity of adverse effects. Evaluation of ADEs, as well as the effect of DDIs on their manifestation, is a non-trivial task and requires numerous experimental and clinical studies. Methodology & Theoretical Orientation: To solve this problem, we developed a computational approach to assess the cardiovascular effects of DDIs. This approach includes: (I) prediction of interaction of individual drugs with human proteins and influence on expression of human genes based on structure-activity relationships implemented in PASS software; (II) selection of proteins and genes that are associated with cardiovascular diseases, participate in functioning of cardiovascular system and expressed in the heart or blood vessels; (III) integration of the resulted profiles and calculation of interaction scores for each cardiovascular effect; (IV) validation of developed approach based on the data on known DDIs. Findings: The developed approach allows predicting the following adverse effects of DDIs: myocardial infarction, ischemic stroke, ventricular tachyarrhythmia, cardiac failure and arterial hypertension. Validation of the approach on known DDIs showed its acceptable accuracy for the studied effects. Conclusion & Significance: The developed approach allows predicting cardiovascular adverse effects of DDIs for drug pairs and provides insights into their molecular mechanisms on the levels of proteins and genes. It can find practical application in the clinic for the selection of the safest combinations of drugs. Recent Publications 1. Ivanov S, Semin M, Lagunin A, Filimonov D, Poroikov V (2017) In silico identification of proteins associated with drug-induced liver injury based on the prediction of drug-target interactions. Mol Inform. 36(7) Doi:10.1002/ minf.201600142. 2. Dmitriev A, Rudik A, Filimonov D, Lagunin A, Pogodin P et al. (2017) Integral estimation of xenobiotics toxicity with regard to their metabolism in human organism. Pure and Applied Chemistry. 89(10):1449-1458. 3. Ivanov SM, Lagunin AA, Poroikov VV (2016) In silico assessment of adverse drug reactions and associated mechanisms. Drug Discov. Today. 21(1):58-71. 4. Ivanov S M, Lagunin A A, Pogodin P V, Filimonov D A, Poroikov V V (2015) Identification of drug targets related to the induction of ventricular tachyarrhythmia through a systems chemical biology approach. Toxicol. Sci. 145(2):321336. 5. Ivanov S M, Lagunin A A, Pogodin P V, Filimonov D A, Poroikov V V (2014) Identification of drug-induced myocardial infarction-related protein targets through the prediction of drug-target interactions and analysis ofbiological processes. Chem. Res. Toxicol. 27(7):1263-1281.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sergey M Ivanov”
- BylineArticles whose byline prints “Maxim I Semin”
- BylineArticles whose byline prints “Alexey A Lagunin”
- BylineArticles whose byline prints “Dmitry A Filimonov”
- BylineArticles whose byline prints “Vladimir V Poroikov”
